FDA Inspection 1255837 — Loyola Univ Medical Center

Loyola Univ Medical Center — FEI 1475369

The FDA completed an inspection of Loyola Univ Medical Center on Dec 5, 2024 in Maywood, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 5, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Maywood, IL (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
907621 CFR 600.12(a)Maintenance - concurrence

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.